Phyllanthus emblica Polysaccharide Improves Metabolic Associated Fatty Liver Disease by Regulating Gut–Liver Axis through Akkermansia and Short-Chain Fatty Acid Receptors
Journal of Agricultural and Food Chemistry · 12.08.2026 · 74 (31) · 24361-24376
DOI: 10.1021/acs.jafc.6c04467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 30.07.2026. Verfasst von Bin Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ganjiang Chinese Medicine Innovation Center , Nanchang330000, China. Hauptthemen laut MEDLINE: Liver, Polysaccharides, Fatty Acids, Volatile, Akkermansia. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
This study investigated the therapeutic effects of PEP-2, a 348.45 kDa pectin isolated from Phyllanthus emblica, against metabolic-associated fatty liver disease (MAFLD). Characterized as a homogalacturonan with minor rhamnogalacturonan I, PEP-2 consists of galacturonic acid, galactose, rhamnose, and arabinose. In high-fat diet-induced mice, PEP-2 significantly improved metabolic phenotypes, reducing obesity, insulin resistance, and hepatic steatosis. Mechanistically, PEP-2 modulated the gut–liver axis by enriching Akkermansia and enhancing short-chain fatty acid (SCFA) production. These changes were associated with increased colonic mRNA expression of SCFA receptor-related genes, including GPR41, GPR43, and GPR109A, and favorable regulation of hepatic lipid metabolism-related genes, including AMPK, PPARα, and CPT1. In vitro, PEP-2 promoted Akkermansia muciniphila growth, while its fermentation products effectively reduced lipid accumulation in cell models. These findings support a microbiota-SCFA-associated mechanism underlying the beneficial effects of PEP-2 and highlight its potential as a prebiotic candidate for functional food development against metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ganjiang Chinese Medicine Innovation Center , Nanchang330000, China.
- Jiangxi Normal University , Nanchang330022, China.
- Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Key Laboratory of Separation Science for Analytical Chemistry, Zhongshan Road 457, Dalian116023, China.
ORCID-Profile: Xuan Jiang, Xinmiao Liang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Zhang, B., Yao, S., Yu, W., Yang, H., Jiang, X., Ye, X., & Liang, X. (2026). Phyllanthus emblica Polysaccharide Improves Metabolic Associated Fatty Liver Disease by Regulating Gut–Liver Axis through Akkermansia and Short-Chain Fatty Acid Receptors. Journal of Agricultural and Food Chemistry, 74(31), 24361-24376. https://doi.org/10.1021/acs.jafc.6c04467
Vancouver
Zhang B, Yao S, Yu W, Yang H, Jiang X, Ye X, et al. Phyllanthus emblica Polysaccharide Improves Metabolic Associated Fatty Liver Disease by Regulating Gut–Liver Axis through Akkermansia and Short-Chain Fatty Acid Receptors. Journal of Agricultural and Food Chemistry. 2026;74(31):24361-24376. doi:10.1021/acs.jafc.6c04467
BibTeX
@article{Zhang2026,
author = {Zhang, Bin and Yao, Siyu and Yu, Wei and Yang, Huilin and Jiang, Xuan and Ye, Xianlong and Liang, Xinmiao},
title = {Phyllanthus emblica Polysaccharide Improves Metabolic Associated Fatty Liver Disease by Regulating Gut–Liver Axis through Akkermansia and Short-Chain Fatty Acid Receptors},
journal = {Journal of Agricultural and Food Chemistry},
year = {2026},
volume = {74},
number = {31},
pages = {24361--24376},
doi = {10.1021/acs.jafc.6c04467}
}
EUVIMED